



|                                                      |  Low (N=54)  | Mild (N=66)  |  High (N=93)  | Total (N=213) | p value|
|:-----------------------------------------------------|:------------:|:------------:|:-------------:|:-------------:|-------:|
|**Avaliable vaccine type**                            |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;wP                                  | 37 (68.52%)  | 54 (81.82%)  |  32 (34.41%)  | 123 (57.75%)  |        |
|&nbsp;&nbsp;&nbsp;aP                                  | 13 (24.07%)  | 10 (15.15%)  |  53 (56.99%)  |  76 (35.68%)  |        |
|&nbsp;&nbsp;&nbsp;Both                                |  4 (7.41%)   |  2 (3.03%)   |   8 (8.60%)   |  14 (6.57%)   |        |
|**Coverage of DTP1 (%)**                              |              |              |               |               |   0.218|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      3       |      8       |       7       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    94.00     |    95.00     |     96.50     |     95.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 81.00, 98.00 | 86.25, 99.00 | 89.00, 98.00  | 87.00, 98.00  |        |
|**Coverage of DTP3 (%)**                              |              |              |               |               |   0.182|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      3       |      8       |       7       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    85.00     |    89.50     |     91.50     |     91.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 75.50, 97.00 | 78.25, 97.00 | 84.25, 96.00  | 78.50, 97.00  |        |
|**General vaccine recommendation**                    |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |     4.00     |     4.00     |     5.00      |     4.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  3.00, 5.00  |  3.00, 5.00  |  4.00, 6.00   |  3.00, 5.00   |        |
|**General vaccine recommendation for toddlers, -3yr** |              |              |               |               |   0.551|
|&nbsp;&nbsp;&nbsp;Median                              |     4.00     |     4.00     |     4.00      |     4.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  3.00, 4.00  |  3.00, 4.00  |  3.00, 4.00   |  3.00, 4.00   |        |
|**General vaccine recommendation for children, 3+yr** |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |     0.00     |     0.00     |     1.00      |     1.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  0.00, 1.00  |  0.00, 1.00  |  0.00, 2.00   |  0.00, 2.00   |        |
|**Time of last shot (months)**                        |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |    18.00     |    18.00     |     72.00     |     48.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 3.22, 60.00  | 3.22, 54.00  | 18.00, 150.00 | 12.00, 120.00 |        |
|**Vaccine recommendation for pregnant**               |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;No                                  | 46 (85.19%)  | 62 (93.94%)  |  60 (64.52%)  | 168 (78.87%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  8 (14.81%)  |  4 (6.06%)   |  33 (35.48%)  |  45 (21.13%)  |        |
|**Vaccine recommendation for adults**                 |              |              |               |               |   0.141|
|&nbsp;&nbsp;&nbsp;No                                  | 49 (90.74%)  | 64 (96.97%)  |  82 (88.17%)  | 195 (91.55%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  5 (9.26%)   |  2 (3.03%)   |  11 (11.83%)  |  18 (8.45%)   |        |
|**Vaccine recommendation for risk groups**            |              |              |               |               |   0.001|
|&nbsp;&nbsp;&nbsp;No                                  | 49 (90.74%)  | 63 (95.45%)  |  71 (76.34%)  | 183 (85.92%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  5 (9.26%)   |  3 (4.55%)   |  22 (23.66%)  |  30 (14.08%)  |        |
|**Pertussis status in 2022/2023**                     |              |              |               |               |   0.027|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      4       |      15      |      10       |      29       |        |
|&nbsp;&nbsp;&nbsp;Low                                 | 25 (50.00%)  | 37 (72.55%)  |  55 (66.27%)  | 117 (63.59%)  |        |
|&nbsp;&nbsp;&nbsp;Normal                              | 11 (22.00%)  |  3 (5.88%)   |  12 (14.46%)  |  26 (14.13%)  |        |
|&nbsp;&nbsp;&nbsp;High                                |  3 (6.00%)   |  0 (0.00%)   |   7 (8.43%)   |  10 (5.43%)   |        |
|&nbsp;&nbsp;&nbsp;Resurgence                          | 11 (22.00%)  | 11 (21.57%)  |  9 (10.84%)   |  31 (16.85%)  |        |
